Treatment for First-Episode Schizophrenia

• Status: Completed
• Trial end date: 2007-05-01
• Target enrollment: 0
• Participant gender: All

Summary

This 3-year study will determine if the antipsychotic medications olanzapine (Zyprexa®) and risperidone (Risperdal®) can help patients with first-episode schizophrenia.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Northwell Health
• Collaborators: National Institute of Mental Health (NIMH); The Zucker Hillside Hospital
• Treatments: Antipsychotic Agents; Olanzapine; Risperidone

Criteria

Inclusion Criteria:

• First episode schizophrenia, schizophreniform disorder or schizoaffective disorder

Exclusion Criteria:

• Prior treatment with antipsychotic medications.